{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:52:53Z","timestamp":1781851973115,"version":"3.54.5"},"reference-count":62,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100200"],"award-info":[{"award-number":["82100200"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhejiang Provincial Medical and Health Science and Technology Plan Project","award":["2025KY1072"],"award-info":[{"award-number":["2025KY1072"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14756366.2026.2674446","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:54:38Z","timestamp":1781531678000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Shikonin suppresses diffuse large B-cell lymphoma progression by inducing ferritinophagy and ferroptosis\n                    <i>via<\/i>\n                    lncRNA ADPGK-AS1 downregulation"],"prefix":"10.1080","volume":"41","author":[{"given":"Can","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hematology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Chen","sequence":"additional","affiliation":[{"name":"Zhejiang Chinese Medical University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilian","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenxian","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8938-1449","authenticated-orcid":false,"given":"Zhenzhen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Affiliated Hangzhou First People\u2019s Hospital, School of Medicine, Westlake University","place":["Hangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"1","key":"e_1_3_6_2_1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.32604\/or.2024.050036","article-title":"Lenalidomide regulates the CCL21\/CCR7\/ERK1\/2 axis to inhibit migration and proliferation in diffuse large B-cell lymphoma","volume":"33","author":"Yang W","year":"2025","unstructured":"Yang W, Tang B, Xu D, Yang W. Lenalidomide regulates the CCL21\/CCR7\/ERK1\/2 axis to inhibit migration and proliferation in diffuse large B-cell lymphoma. Oncol Res. 2025;33(1):199\u2013212.","journal-title":"Oncol Res"},{"key":"e_1_3_6_3_1","doi-asserted-by":"crossref","first-page":"1412743","DOI":"10.3389\/fphar.2024.1412743","article-title":"Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China","volume":"15","author":"Li R","year":"2024","unstructured":"Li R, Zeng Y, Chen Y, Ye Z, Chen C, Yang J, Fu J, Zhou T, Jiang D, Qin S, et\u00a0al. Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China. Front Pharmacol. 2024;15:1412743.","journal-title":"Front Pharmacol"},{"issue":"1","key":"e_1_3_6_4_1","doi-asserted-by":"crossref","first-page":"e70565","DOI":"10.1002\/cam4.70565","article-title":"Influence of organ-specific extranodal involvement on survival outcomes in stage IV diffuse large B-cell lymphoma","volume":"14","author":"Kim T-Y","year":"2025","unstructured":"Kim T-Y, Kim T-J, Han EJ, Min GJ, Park S-S, Park S, Yoon J-H, Lee S-E, Cho B-S, Eom K-S, et\u00a0al. Influence of organ-specific extranodal involvement on survival outcomes in stage IV diffuse large B-cell lymphoma. Cancer Med. 2025;14(1):e70565.","journal-title":"Cancer Med"},{"key":"e_1_3_6_5_1","doi-asserted-by":"crossref","first-page":"101470","DOI":"10.1016\/j.molmet.2022.101470","article-title":"Ferroptosis and ferritinophagy in diabetes complications","volume":"60","author":"He J","year":"2022","unstructured":"He J, Li Z, Xia P, Shi A, FuChen X, Zhang J, Yu P. Ferroptosis and ferritinophagy in diabetes complications. Mol Metab. 2022;60:101470.","journal-title":"Mol Metab"},{"issue":"6","key":"e_1_3_6_6_1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon SJ","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25(6):424\u2013442.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"e_1_3_6_7_1","doi-asserted-by":"crossref","first-page":"105920","DOI":"10.1016\/j.neuint.2024.105920","article-title":"Ferritinophagy promotes microglia ferroptosis to aggravate neuroinflammation induced by cerebral ischemia-reperfusion injury via activation of the cGAS-STING signaling pathway","volume":"183","author":"Sui H","year":"2025","unstructured":"Sui H, Sun Z, Liu C, Xi H. Ferritinophagy promotes microglia ferroptosis to aggravate neuroinflammation induced by cerebral ischemia-reperfusion injury via activation of the cGAS-STING signaling pathway. Neurochem Int. 2025;183:105920.","journal-title":"Neurochem Int"},{"key":"e_1_3_6_8_1","doi-asserted-by":"crossref","first-page":"1482354","DOI":"10.3389\/fphar.2024.1482354","article-title":"Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy","volume":"15","author":"Zhang C","year":"2024","unstructured":"Zhang C, Zhan S, He Y, Pan Z, You Z, Zhu X, Lin Q. Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy. Front Pharmacol. 2024;15:1482354.","journal-title":"Front Pharmacol"},{"issue":"7498","key":"e_1_3_6_9_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias JD","year":"2014","unstructured":"Mancias JD, Wang X, Gygi SP, Harper JW, Kimmelman AC. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014;509(7498):105\u2013109.","journal-title":"Nature"},{"key":"e_1_3_6_10_1","doi-asserted-by":"crossref","first-page":"104463","DOI":"10.1016\/j.phrs.2019.104463","article-title":"Pharmacological properties and derivatives of shikonin\u2013a review in recent years","volume":"149","author":"Guo C","year":"2019","unstructured":"Guo C, He J, Song X, Tan L, Wang M, Jiang P, Li Y, Cao Z, Peng C. Pharmacological properties and derivatives of shikonin\u2013a review in recent years. Pharmacol Res. 2019;149:104463.","journal-title":"Pharmacol Res"},{"key":"e_1_3_6_11_1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.canlet.2019.04.033","article-title":"Shikonin derivatives for cancer prevention and therapy","volume":"459","author":"Boulos JC","year":"2019","unstructured":"Boulos JC, Rahama M, Hegazy M-EF, Efferth T. Shikonin derivatives for cancer prevention and therapy. Cancer Lett. 2019;459:248\u2013267.","journal-title":"Cancer Lett"},{"issue":"8","key":"e_1_3_6_12_1","doi-asserted-by":"crossref","first-page":"148210","DOI":"10.1016\/j.bbabio.2020.148210","article-title":"Mitochondria-targeted 1,4-naphthoquinone (SkQN) is a powerful prooxidant and cytotoxic agent","volume":"1861","author":"Goleva TN","year":"2020","unstructured":"Goleva TN, Lyamzaev KG, Rogov AG, Khailova LS, Epremyan KK, Shumakovich GP, Domnina LV, Ivanova OY, Marmiy NV, Zinevich TV, et\u00a0al. Mitochondria-targeted 1,4-naphthoquinone (SkQN) is a powerful prooxidant and cytotoxic agent. Biochim Biophys Acta Bioenerg. 2020;1861(8):148210.","journal-title":"Biochim Biophys Acta Bioenerg"},{"key":"e_1_3_6_13_1","doi-asserted-by":"crossref","first-page":"905755","DOI":"10.3389\/fphar.2022.905755","article-title":"Review of shikonin and derivatives: isolation, chemistry, biosynthesis, pharmacology and toxicology","volume":"13","author":"Yadav S","year":"2022","unstructured":"Yadav S, Sharma A, Nayik GA, Cooper R, Bhardwaj G, Sohal HS, Mutreja V, Kaur R, Areche FO, AlOudat M, et\u00a0al. Review of shikonin and derivatives: isolation, chemistry, biosynthesis, pharmacology and toxicology. Front Pharmacol. 2022;13:905755.","journal-title":"Front Pharmacol"},{"issue":"1","key":"e_1_3_6_14_1","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1038\/s41598-018-21570-z","article-title":"Shikonin exerts antitumor activity in Burkitt\u2019s lymphoma by inhibiting C-MYC and PI3K\/AKT\/mTOR pathway and acts synergistically with doxorubicin","volume":"8","author":"Ni F","year":"2018","unstructured":"Ni F, Huang X, Chen Z, Qian W, Tong X. Shikonin exerts antitumor activity in Burkitt\u2019s lymphoma by inhibiting C-MYC and PI3K\/AKT\/mTOR pathway and acts synergistically with doxorubicin. Sci Rep. 2018;8(1):3317.","journal-title":"Sci Rep"},{"key":"e_1_3_6_15_1","doi-asserted-by":"crossref","first-page":"1490759","DOI":"10.3389\/fphar.2024.1490759","article-title":"Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT\/GPX4 regulatory axis","volume":"15","author":"Huang R","year":"2024","unstructured":"Huang R, Chu D, Shi J, Xu R, Wang K. Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf2 ubiquitination and inhibiting the xCT\/GPX4 regulatory axis. Front Pharmacol. 2024;15:1490759.","journal-title":"Front Pharmacol"},{"key":"e_1_3_6_16_1","doi-asserted-by":"crossref","first-page":"1025067","DOI":"10.3389\/fonc.2022.1025067","article-title":"Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy","volume":"12","author":"Li W","year":"2022","unstructured":"Li W, Fu H, Fang L, Chai H, Gao T, Chen Z, Qian S. Shikonin induces ferroptosis in multiple myeloma via GOT1-mediated ferritinophagy. Front Oncol. 2022;12:1025067.","journal-title":"Front Oncol"},{"issue":"2","key":"e_1_3_6_17_1","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.1080\/21655979.2022.2034584","article-title":"Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway","volume":"13","author":"Cui J","year":"2022","unstructured":"Cui J, Guo R, Wang Y, Song Y, Song X, Li H, Song X, Li J. Acetylshikonin suppresses diffuse large B-Cell Lymphoma cell growth by targeting the T-lymphokine-activated killer cell-originated protein kinase signalling pathway. Bioengineered. 2022;13(2):4428\u20134440.","journal-title":"Bioengineered"},{"key":"e_1_3_6_18_1","doi-asserted-by":"crossref","first-page":"110588","DOI":"10.1016\/j.cbi.2023.110588","article-title":"Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation","volume":"382","author":"Qian X","year":"2023","unstructured":"Qian X, Zhu L, Xu M, Liu H, Yu X, Shao Q, Qin J. Shikonin suppresses small cell lung cancer growth via inducing ATF3-mediated ferroptosis to promote ROS accumulation. Chem Biol Interact. 2023;382:110588.","journal-title":"Chem Biol Interact"},{"key":"e_1_3_6_19_1","doi-asserted-by":"crossref","first-page":"156139","DOI":"10.1016\/j.phymed.2024.156139","article-title":"Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1\u03b1\/HO-1 axis","volume":"135","author":"Lu C","year":"2024","unstructured":"Lu C, Zhang Z, Fan Y, Wang X, Qian J, Bian Z. Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1\u03b1\/HO-1 axis. Phytomedicine. 2024;135:156139.","journal-title":"Phytomedicine"},{"key":"e_1_3_6_20_1","doi-asserted-by":"crossref","first-page":"154701","DOI":"10.1016\/j.phymed.2023.154701","article-title":"Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe(2+) accumulation","volume":"112","author":"Ni M","year":"2023","unstructured":"Ni M, Zhou J, Zhu Z, Xu Q, Yin Z, Wang Y, Zheng Z, Zhao H. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe(2+) accumulation. Phytomedicine. 2023;112:154701.","journal-title":"Phytomedicine"},{"issue":"3","key":"e_1_3_6_21_1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","article-title":"On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death","volume":"3","author":"Zilka O","year":"2017","unstructured":"Zilka O, Shah R, Li B, Friedmann Angeli JP, Griesser M, Conrad M, Pratt DA. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci. 2017;3(3):232\u2013243.","journal-title":"ACS Cent Sci"},{"issue":"5","key":"e_1_3_6_22_1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon SJ","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et\u00a0al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060\u20131072.","journal-title":"Cell"},{"issue":"14","key":"e_1_3_6_23_1","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell BR.","year":"2022","unstructured":"Stockwell BR. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell. 2022;185(14):2401\u20132421.","journal-title":"Cell"},{"issue":"9","key":"e_1_3_6_24_1","first-page":"453","article-title":"[Malondialdehyde (MDA) as a lipid peroxidation marker]","volume":"57","author":"Gawe\u0142 S","year":"2004","unstructured":"Gawe\u0142 S, Wardas M, Niedworok E, Wardas P. [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiad Lek. 2004;57(9\u201310):453\u2013455.","journal-title":"Wiad Lek"},{"issue":"7","key":"e_1_3_6_25_1","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1080\/15548627.2023.2170960","article-title":"ATM orchestrates ferritinophagy and ferroptosis by phosphorylating NCOA4","volume":"19","author":"Wu H","year":"2023","unstructured":"Wu H, Liu Q, Shan X, Gao W, Chen Q. ATM orchestrates ferritinophagy and ferroptosis by phosphorylating NCOA4. Autophagy. 2023;19(7):2062\u20132077.","journal-title":"Autophagy"},{"issue":"1","key":"e_1_3_6_26_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-8981(99)00222-3","article-title":"Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias","volume":"293","author":"Devi GS","year":"2000","unstructured":"Devi GS, Prasad MH, Saraswathi I, Raghu D, Rao DN, Reddy PP. Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clin Chim Acta. 2000;293(1\u20132):53\u201362.","journal-title":"Clin Chim Acta"},{"key":"e_1_3_6_27_1","doi-asserted-by":"crossref","first-page":"116029","DOI":"10.1016\/j.jep.2022.116029","article-title":"Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro","volume":"303","author":"Li Q","year":"2023","unstructured":"Li Q, Peng F, Yan X, Chen Y, Zhou J, Wu S, Jiang W, Jin X, Liang J, Peng C, et\u00a0al. Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro. J Ethnopharmacol. 2023;303:116029.","journal-title":"J Ethnopharmacol"},{"key":"e_1_3_6_28_1","doi-asserted-by":"crossref","first-page":"111285","DOI":"10.1016\/j.cellsig.2024.111285","article-title":"Thiostrepton induces oxidative stress, mitochondrial dysfunction and ferroptosis in HaCaT cells","volume":"121","author":"Chen M","year":"2024","unstructured":"Chen M, Wang Q, Wang Y, Xuan Y, Shen M, Hu X, Li Y, Guo Y, Wang J, Tan F, et\u00a0al. Thiostrepton induces oxidative stress, mitochondrial dysfunction and ferroptosis in HaCaT cells. Cell Signal. 2024;121:111285.","journal-title":"Cell Signal"},{"issue":"51","key":"e_1_3_6_29_1","doi-asserted-by":"crossref","first-page":"88658","DOI":"10.18632\/oncotarget.20809","article-title":"Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57","volume":"8","author":"Zhang C-H","year":"2017","unstructured":"Zhang C-H, Wang J, Zhang L-X, Lu Y-H, Ji T-H, Xu L, Ling L-J. Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57. Oncotarget. 2017;8(51):88658\u201388669.","journal-title":"Oncotarget"},{"issue":"1","key":"e_1_3_6_30_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s10020-020-00152-8","article-title":"Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer","volume":"26","author":"Zang F","year":"2020","unstructured":"Zang F, Rao Y, Zhu X, Wu Z, Jiang H. Shikonin suppresses NEAT1 and Akt signaling in treating paclitaxel-resistant non-small cell of lung cancer. Mol Med. 2020;26(1):28.","journal-title":"Mol Med"},{"issue":"9","key":"e_1_3_6_31_1","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3390\/ijms17091483","article-title":"Mammalian metallothionein-2A and oxidative stress","volume":"17","author":"Ling X-B","year":"2016","unstructured":"Ling X-B, Wei H-W, Wang J, Kong Y-Q, Wu Y-Y, Guo J-L, Li T-F, Li J-K. Mammalian metallothionein-2A and oxidative stress. Int J Mol Sci. 2016;17(9):1483.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"e_1_3_6_32_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","article-title":"Gene regulation by long non-coding RNAs and its biological functions","volume":"22","author":"Statello L","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"e_1_3_6_33_1","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nm1784","article-title":"Expression of a noncoding RNA is elevated in Alzheimer\u2019s disease and drives rapid feed-forward regulation of beta-secretase","volume":"14","author":"Faghihi MA","year":"2008","unstructured":"Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, Finch CE, St Laurent G, Kenny PJ, Wahlestedt C, et\u00a0al. Expression of a noncoding RNA is elevated in Alzheimer\u2019s disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008;14(7):723\u2013730.","journal-title":"Nat Med"},{"issue":"1","key":"e_1_3_6_34_1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cell.2014.08.018","article-title":"RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites","volume":"159","author":"Engreitz JM","year":"2014","unstructured":"Engreitz JM, Sirokman K, McDonel P, Shishkin AA, Surka C, Russell P, Grossman SR, Chow AY, Guttman M, Lander ES, et\u00a0al. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites. Cell. 2014;159(1):188\u2013199.","journal-title":"Cell"},{"issue":"7431","key":"e_1_3_6_35_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature11661","article-title":"Control of somatic tissue differentiation by the long non-coding RNA TINCR","volume":"493","author":"Kretz M","year":"2013","unstructured":"Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, Chow J, et\u00a0al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2013;493(7431):231\u2013235.","journal-title":"Nature"},{"key":"e_1_3_6_36_1","doi-asserted-by":"crossref","first-page":"W119","DOI":"10.1093\/nar\/gku359","article-title":"CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains","volume":"42","author":"Wright PR","year":"2014","unstructured":"Wright PR, Georg J, Mann M, Sorescu DA, Richter AS, Lott S, Kleinkauf R, Hess WR, Backofen R. CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains. Nucleic Acids Res. 2014;42(Web Server Issue):W119\u2013W123.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"e_1_3_6_37_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/bib\/bbv031","article-title":"Revealing protein-lncRNA interaction","volume":"17","author":"Ferr\u00e8 F","year":"2016","unstructured":"Ferr\u00e8 F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17(1):106\u2013116.","journal-title":"Brief Bioinform"},{"issue":"8","key":"e_1_3_6_38_1","first-page":"1106","article-title":"Assessing the partners of the RBP9-mRNP complex in Trypanosoma cruzi using shotgun proteomics and RNA-seq","volume":"15","author":"Wippel HH","year":"2018","unstructured":"Wippel HH, Inoue AH, Vidal NM, Costa JF, Marcon BH, Romagnoli BAA, Santos MDM, Carvalho PC, Goldenberg S, Alves LR, et\u00a0al. Assessing the partners of the RBP9-mRNP complex in Trypanosoma cruzi using shotgun proteomics and RNA-seq. RNA Biol. 2018;15(8):1106\u20131118.","journal-title":"RNA Biol"},{"issue":"1","key":"e_1_3_6_39_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1146\/annurev.physiol.60.1.575","article-title":"The many roles of c-Myc in apoptosis","volume":"60","author":"Thompson EB.","year":"1998","unstructured":"Thompson EB. The many roles of c-Myc in apoptosis. Annu Rev Physiol. 1998;60(1):575\u2013600.","journal-title":"Annu Rev Physiol"},{"issue":"15","key":"e_1_3_6_40_1","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz R","year":"2018","unstructured":"Schmitz R, Wright GW, Huang DW, Johnson CA, Phelan JD, Wang JQ, Roulland S, Kasbekar M, Young RM, Shaffer AL, et\u00a0al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med. 2018;378(15):1396\u20131407.","journal-title":"N Engl J Med"},{"issue":"1","key":"e_1_3_6_41_1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-023-02688-z","article-title":"Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery","volume":"42","author":"Long L","year":"2023","unstructured":"Long L, Xiong W, Lin F, Hou J, Chen G, Peng T, He Y, Wang R, Xu Q, Huang Y, et\u00a0al. Regulating lactate-related immunometabolism and EMT reversal for colorectal cancer liver metastases using shikonin targeted delivery. J Exp Clin Cancer Res. 2023;42(1):117.","journal-title":"J Exp Clin Cancer Res"},{"key":"e_1_3_6_42_1","doi-asserted-by":"crossref","first-page":"155214","DOI":"10.1016\/j.phymed.2023.155214","article-title":"Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect","volume":"123","author":"Hu X","year":"2024","unstructured":"Hu X, Peng X, Zhang Y, Fan S, Liu X, Song Y, Ren S, Chen L, Chen Y, Wang R, et\u00a0al. Shikonin reverses cancer-associated fibroblast-induced gemcitabine resistance in pancreatic cancer cells by suppressing monocarboxylate transporter 4-mediated reverse Warburg effect. Phytomedicine. 2024;123:155214.","journal-title":"Phytomedicine"},{"issue":"8","key":"e_1_3_6_43_1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/cr.2008.86","article-title":"Induction of apoptosis by shikonin through a ROS\/JNK-mediated process in Bcr\/Abl-positive chronic myelogenous leukemia (CML) cells","volume":"18","author":"Mao X","year":"2008","unstructured":"Mao X, Yu CR, Li WH, Li WX. Induction of apoptosis by shikonin through a ROS\/JNK-mediated process in Bcr\/Abl-positive chronic myelogenous leukemia (CML) cells. Cell Res. 2008;18(8):879\u2013888.","journal-title":"Cell Res"},{"key":"e_1_3_6_44_1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.freeradbiomed.2014.02.016","article-title":"Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells","volume":"70","author":"Duan D","year":"2014","unstructured":"Duan D, Zhang B, Yao J, Liu Y, Fang J. Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells. Free Radic Biol Med. 2014;70:182\u2013193.","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"e_1_3_6_45_1","doi-asserted-by":"crossref","first-page":"101108","DOI":"10.1016\/j.tranon.2021.101108","article-title":"Corrigendum to \u2018ROS mediated apoptotic pathways in primary effusion lymphoma: comment on induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic pathways in primary effusion lymphoma\u2019 [Transl. Oncol. 2021; Article 101061]","volume":"14","author":"Dwivedi P.","year":"2021","unstructured":"Dwivedi P. Corrigendum to \u2018ROS mediated apoptotic pathways in primary effusion lymphoma: comment on induction of apoptosis by Shikonin through ROS-mediated intrinsic and extrinsic pathways in primary effusion lymphoma\u2019 [Transl. Oncol. 2021; Article 101061]. Transl Oncol. 2021;14(7):101108.","journal-title":"Transl Oncol"},{"issue":"4","key":"e_1_3_6_46_1","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12040864","article-title":"Shikonin induces ROS-dependent apoptosis via mitochondria depolarization and ER stress in adult T cell leukemia\/lymphoma","volume":"12","author":"Boonnate P","year":"2023","unstructured":"Boonnate P, Kariya R, Okada S. Shikonin induces ROS-dependent apoptosis via mitochondria depolarization and ER stress in adult T cell leukemia\/lymphoma. Antioxidants. 2023;12(4):864.","journal-title":"Antioxidants"},{"issue":"3","key":"e_1_3_6_47_1","doi-asserted-by":"crossref","first-page":"101006","DOI":"10.1016\/j.tranon.2020.101006","article-title":"Induction of apoptosis by shikonin through ROS-mediated intrinsic and extrinsic apoptotic pathways in primary effusion lymphoma","volume":"14","author":"Alam MM","year":"2021","unstructured":"Alam MM, Kariya R, Boonnate P, Kawaguchi A, Okada S. Induction of apoptosis by shikonin through ROS-mediated intrinsic and extrinsic apoptotic pathways in primary effusion lymphoma. Transl Oncol. 2021;14(3):101006.","journal-title":"Transl Oncol"},{"issue":"4","key":"e_1_3_6_48_1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang X","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u2013282.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"e_1_3_6_49_1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3390\/ph11040114","article-title":"The role of NCOA4-mediated ferritinophagy in health and disease","volume":"11","author":"Santana-Codina N","year":"2018","unstructured":"Santana-Codina N, Mancias JD. The role of NCOA4-mediated ferritinophagy in health and disease. Pharmaceuticals. 2018;11(4):114.","journal-title":"Pharmaceuticals"},{"issue":"7","key":"e_1_3_6_50_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei G","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u2013396.","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"e_1_3_6_51_1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2174\/0115680096274757231219072003","article-title":"Tectorigenin inhibits glycolysis-induced cell growth and proliferation by modulating LncRNA CCAT2\/miR-145 pathway in colorectal cancer","volume":"24","author":"Xing Y","year":"2024","unstructured":"Xing Y, Lin B, Liu B, Shao J, Jin Z. Tectorigenin inhibits glycolysis-induced cell growth and proliferation by modulating LncRNA CCAT2\/miR-145 pathway in colorectal cancer. Curr Cancer Drug Targets. 2024;24(10):1071\u20131079.","journal-title":"Curr Cancer Drug Targets"},{"issue":"11","key":"e_1_3_6_52_1","doi-asserted-by":"crossref","first-page":"18260","DOI":"10.18632\/oncotarget.15353","article-title":"Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184","volume":"8","author":"Zhou Y","year":"2017","unstructured":"Zhou Y, Wang X, Zhang J, He A, Wang YL, Han K, Su Y, Yin J, Lv X, Hu H, et\u00a0al. Artesunate suppresses the viability and mobility of prostate cancer cells through UCA1, the sponge of miR-184. Oncotarget. 2017;8(11):18260\u201318270.","journal-title":"Oncotarget"},{"key":"e_1_3_6_53_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.canlet.2018.11.028","article-title":"Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling","volume":"443","author":"Wang S-S","year":"2019","unstructured":"Wang S-S, Lv Y, Xu X-C, Zuo Y, Song Y, Wu G-P, Lu P-H, Zhang Z-Q, Chen M-B. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling. Cancer Lett. 2019;443:13\u201324.","journal-title":"Cancer Lett"},{"issue":"2","key":"e_1_3_6_54_1","article-title":"Corylin suppresses hepatocellular carcinoma progression via the inhibition of epithelial-mesenchymal transition, mediated by long noncoding RNA GAS5","volume":"19","author":"Chen C-Y","year":"2018","unstructured":"Chen C-Y, Chen C-C, Shieh T-M, Hsueh C, Wang S-H, Leu Y-L, Lian J-H, Wang T-H. Corylin suppresses hepatocellular carcinoma progression via the inhibition of epithelial-mesenchymal transition, mediated by long noncoding RNA GAS5. Int J Mol Sci. 2018;19(2):380.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"e_1_3_6_55_1","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","article-title":"LncRNA: a link between RNA and cancer","volume":"1839","author":"Yang G","year":"2014","unstructured":"Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097\u20131109.","journal-title":"Biochim Biophys Acta"},{"issue":"18","key":"e_1_3_6_56_1","doi-asserted-by":"crossref","first-page":"e111620","DOI":"10.15252\/embj.2022111620","article-title":"ADPGK-AS1 long noncoding RNA switches macrophage metabolic and phenotypic state to promote lung cancer growth","volume":"42","author":"Karger A","year":"2023","unstructured":"Karger A, Mansouri S, Leisegang MS, Weigert A, G\u00fcnther S, Kuenne C, Wittig I, Zukunft S, Klatt S, Aliraj B, et\u00a0al. ADPGK-AS1 long noncoding RNA switches macrophage metabolic and phenotypic state to promote lung cancer growth. EMBO J. 2023;42(18):e111620.","journal-title":"EMBO J"},{"issue":"7","key":"e_1_3_6_57_1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/15384047.2018.1423912","article-title":"LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition","volume":"19","author":"Song S","year":"2018","unstructured":"Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition. Cancer Biol Ther. 2018;19(7):573\u2013583.","journal-title":"Cancer Biol Ther"},{"issue":"5","key":"e_1_3_6_58_1","first-page":"2380","article-title":"ADPGK-AS1 promotes the progression of colorectal cancer via sponging miR-525 to upregulate FUT1","volume":"24","author":"Jiang HY","year":"2020","unstructured":"Jiang HY, Wang ZJ. ADPGK-AS1 promotes the progression of colorectal cancer via sponging miR-525 to upregulate FUT1. Eur Rev Med Pharmacol Sci. 2020;24(5):2380\u20132386.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"e_1_3_6_59_1","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/s11626-019-00372-1","article-title":"Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196\/OTX1 axis in breast cancer","volume":"55","author":"Yang J","year":"2019","unstructured":"Yang J, Wu W, Wu M, Ding J. Long noncoding RNA ADPGK-AS1 promotes cell proliferation, migration, and EMT process through regulating miR-3196\/OTX1 axis in breast cancer. In Vitro Cell Dev Biol Anim. 2019;55(7):522\u2013532.","journal-title":"In Vitro Cell Dev Biol Anim"},{"issue":"1","key":"e_1_3_6_60_1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12935-022-02623-w","article-title":"Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1\/LATS2\/YAP1 signaling pathway in colorectal cancer","volume":"22","author":"Liu X","year":"2022","unstructured":"Liu X, Quan J, Shen Z, Zhang Z, Chen Z, Li L, Li X, Hu G, Deng X. Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1\/LATS2\/YAP1 signaling pathway in colorectal cancer. Cancer Cell Int. 2022;22(1):205.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"e_1_3_6_61_1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","article-title":"The roles of metallothioneins in carcinogenesis","volume":"11","author":"Si M","year":"2018","unstructured":"Si M, Lang J. The roles of metallothioneins in carcinogenesis. J Hematol Oncol. 2018;11(1):107.","journal-title":"J Hematol Oncol"},{"issue":"15","key":"e_1_3_6_62_1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1089\/ars.2014.6128","article-title":"Epigenetic upregulation of metallothionein 2A by diallyl trisulfide enhances chemosensitivity of human gastric cancer cells to docetaxel through attenuating NF-\u03baB activation","volume":"24","author":"Pan Y","year":"2016","unstructured":"Pan Y, Lin S, Xing R, Zhu M, Lin B, Cui J, Li W, Gao J, Shen L, Zhao Y, et\u00a0al. Epigenetic upregulation of metallothionein 2A by diallyl trisulfide enhances chemosensitivity of human gastric cancer cells to docetaxel through attenuating NF-\u03baB activation. Antioxid Redox Signal. 2016;24(15):839\u2013854.","journal-title":"Antioxid Redox Signal"},{"issue":"25","key":"e_1_3_6_63_1","doi-asserted-by":"crossref","first-page":"e2300008120","DOI":"10.1073\/pnas.2300008120","article-title":"The mRNA translation initiation factor eIF4G1 controls mitochondrial oxidative phosphorylation, axonal morphogenesis, and memory","volume":"120","author":"Kim SH","year":"2023","unstructured":"Kim SH, et\u00a0al. The mRNA translation initiation factor eIF4G1 controls mitochondrial oxidative phosphorylation, axonal morphogenesis, and memory. Proc Natl Acad Sci USA. 2023;120(25):e2300008120.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Enzyme Inhibition and Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2674446","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14756366.2026.2674446","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14756366.2026.2674446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T06:13:23Z","timestamp":1781849603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14756366.2026.2674446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14756366.2026.2674446"],"URL":"https:\/\/doi.org\/10.1080\/14756366.2026.2674446","relation":{},"ISSN":["1475-6366","1475-6374"],"issn-type":[{"value":"1475-6366","type":"print"},{"value":"1475-6374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ienz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2674446"}}